HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hirofumi Hanaoka Selected Research

galactosyl serum albumin-rhodamine green

3/2014Fluorescence-lifetime molecular imaging can detect invisible peritoneal ovarian tumors in bloody ascites.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hirofumi Hanaoka Research Topics

Disease

57Neoplasms (Cancer)
01/2022 - 07/2005
5Hypoxia (Hypoxemia)
03/2021 - 12/2006
5Neoplasm Metastasis (Metastasis)
04/2019 - 05/2006
3Triple Negative Breast Neoplasms
04/2021 - 01/2018
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2019 - 04/2010
3Hypoglycemia (Reactive Hypoglycemia)
01/2018 - 01/2013
3Hepatocellular Carcinoma (Hepatoma)
06/2015 - 12/2007
3Ovarian Neoplasms (Ovarian Cancer)
01/2015 - 02/2014
3Colorectal Neoplasms (Colorectal Cancer)
08/2012 - 01/2011
2Diabetic Cardiomyopathies
12/2021 - 11/2020
2Neuroendocrine Tumors (Neuroendocrine Tumor)
04/2019 - 09/2010
2Lung Neoplasms (Lung Cancer)
01/2018 - 08/2006
2Insulin Resistance
12/2017 - 01/2014
2Lymphoma (Lymphomas)
11/2017 - 08/2006
2Hypothermia
02/2015 - 01/2014
2Breast Neoplasms (Breast Cancer)
04/2010 - 08/2006
2Synovial Sarcoma (Synovioma)
07/2009 - 02/2008
2Pain (Aches)
01/2009 - 07/2005
1Platelet Glycoprotein IV Deficiency
12/2021
1Dent Disease
12/2021
1Acute Kidney Injury (Acute Renal Failure)
12/2021
1Inborn Genetic Diseases (Disease, Hereditary)
12/2021
1Experimental Arthritis
03/2021
1Type 2 Diabetes Mellitus (MODY)
01/2021
1Neuroblastoma
01/2021
1Urinary Bladder Neoplasms (Bladder Cancer)
05/2020
1Melanoma (Melanoma, Malignant)
10/2019

Drug/Important Bio-Agent (IBA)

11Glucose (Dextrose)FDA LinkGeneric
01/2018 - 08/2006
8Monoclonal AntibodiesIBA
11/2018 - 07/2005
7Therapeutic UsesIBA
11/2021 - 03/2014
7Amino AcidsFDA Link
11/2021 - 08/2011
6Fatty Acids (Saturated Fatty Acids)IBA
12/2021 - 01/2014
6RadiopharmaceuticalsIBA
03/2021 - 07/2005
6Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
05/2020 - 08/2006
6Photosensitizing Agents (Photosensitizers)IBA
11/2017 - 05/2014
5Amino Acid Transport Systems (Amino Acid Transporter)IBA
11/2021 - 10/2010
5Radioisotopes (Radionuclides)IBA
11/2020 - 02/2008
5ErbB Receptors (EGF Receptor)IBA
10/2019 - 03/2012
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018 - 08/2010
5AntibodiesIBA
03/2016 - 11/2010
41,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
10/2019 - 07/2009
4Peptides (Polypeptides)IBA
10/2019 - 05/2006
4Yttrium-90IBA
01/2018 - 02/2008
4Deoxyglucose (2 Deoxy D glucose)IBA
02/2014 - 02/2007
3Fatty Acid-Binding ProteinsIBA
12/2021 - 11/2018
3Biomarkers (Surrogate Marker)IBA
12/2021 - 01/2018
3Bevacizumab (Avastin)FDA Link
04/2021 - 01/2011
3phenylalanine methyl esterIBA
05/2020 - 05/2015
3Cetuximab (Erbitux)FDA Link
10/2019 - 03/2012
3LigandsIBA
11/2018 - 04/2016
3Indium-111IBA
01/2018 - 07/2009
3Proteins (Proteins, Gene)FDA Link
02/2014 - 01/2004
3Biological ProductsIBA
02/2014 - 08/2010
3Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
02/2014 - 08/2010
3Tyrosine (L-Tyrosine)FDA Link
05/2013 - 10/2010
2Organic Anion TransportersIBA
01/2022 - 11/2021
2Probenecid (Benemid)FDA LinkGeneric
01/2022 - 11/2021
2Streptozocin (Streptozotocin)FDA Link
12/2021 - 11/2020
2AvidinIBA
04/2021 - 01/2018
2Somatostatin Receptors (Somatostatin Receptor)IBA
04/2019 - 08/2009
2GalliumIBA
04/2019 - 01/2018
2Durapatite (Hydroxylapatite)IBA
04/2019 - 07/2013
2Coloring Agents (Dyes)IBA
11/2018 - 01/2015
23-Iodobenzylguanidine (Iobenguane)IBA
02/2018 - 09/2010
2Adenosine Triphosphate (ATP)IBA
01/2018 - 01/2018
2Panitumumab (Vectibix)FDA Link
01/2018 - 05/2014
2Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA
01/2018 - 09/2010
2Immunoglobulin FragmentsIBA
01/2018 - 01/2015
2GlypicansIBA
06/2015 - 01/2015
2Trastuzumab (Herceptin)FDA Link
01/2015 - 04/2010
2phthalocyanineIBA
01/2015 - 01/2015
2Immunoglobulin G (IgG)IBA
04/2014 - 11/2010
2Galactose (Galactopyranose)FDA LinkGeneric
03/2014 - 02/2014
2HexokinaseIBA
02/2014 - 05/2012
2Pharmaceutical PreparationsIBA
01/2014 - 03/2012
2Matrix Metalloproteinase InhibitorsIBA
01/2014 - 07/2007
2SolutionsIBA
09/2010 - 08/2009
2Matrix Metalloproteinases (MMPs)IBA
05/2010 - 07/2007
2Diphosphonates (Bisphosphonates)IBA
01/2009 - 07/2005
1Low Density Lipoprotein Receptor-Related Protein-2IBA
12/2021
1Astatine-211IBA
11/2021
1StreptavidinIBA
04/2021
1procaine isothiocyanate (PRIT)IBA
04/2021
1Mannose ReceptorIBA
03/2021
1Dextrans (Dextran)FDA Link
03/2021
1benzylguanidineIBA
01/2021
1IncretinsIBA
01/2021
1LipidsIBA
11/2020
1Phenylalanine (L-Phenylalanine)FDA Link
11/2020
1DNA (Deoxyribonucleic Acid)IBA
11/2020
1CopperIBA
01/2020
1Melanocyte-Stimulating Hormones (MSH)IBA
10/2019
1Type 1 Melanocortin ReceptorIBA
10/2019
1alpha-MSHIBA
10/2019

Therapy/Procedure

17Therapeutics
11/2021 - 07/2005
7Radioimmunotherapy
04/2021 - 07/2005
3Radiotherapy
12/2021 - 12/2006
3Aftercare (After-Treatment)
11/2021 - 07/2009
2Intravenous Injections
01/2014 - 08/2012
1Heavy Ion Radiotherapy
12/2021